MiNK Therapeutics, Inc. (INKT)
9.57
-0.65
(-6.40%)
USD |
NASDAQ |
Nov 12, 16:00
9.57
0.00 (0.00%)
After-Hours: 18:51
MiNK Therapeutics Shareholders Equity (Quarterly) : -14.03M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.03M |
| March 31, 2026 | -12.69M |
| December 31, 2025 | -14.23M |
| September 30, 2025 | -13.51M |
| June 30, 2025 | -25.19M |
| March 31, 2025 | -21.79M |
| December 31, 2024 | -19.59M |
| September 30, 2024 | -17.55M |
| June 30, 2024 | -16.58M |
| March 31, 2024 | -20.30M |
| December 31, 2023 | -18.06M |
| Date | Value |
|---|---|
| September 30, 2023 | -13.58M |
| June 30, 2023 | -9.495M |
| March 31, 2023 | -4.476M |
| December 31, 2022 | -0.4013M |
| September 30, 2022 | 6.756M |
| June 30, 2022 | 13.69M |
| March 31, 2022 | 17.31M |
| December 31, 2021 | 23.78M |
| September 30, 2021 | -76.51M |
| June 30, 2021 | -63.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Vericel Corp. | 384.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.615M |
| Total Liabilities (Quarterly) | 23.64M |
| Current Ratio | 1.228 |
| Net Debt Paydown Yield | 1.72% |